Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00754-20
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Hypothesis: Advanced Biotechnological Treatment Approaches Against SARS-CoV-2 (COVID-19)

Volume 5 - 2020, Issue 4 - April
2020English

Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19

Viruses
VirologyInfectious Diseases
2020English

Important Steps to Control COVID-19/SARS-CoV-2 Infection

SN Comprehensive Clinical Medicine
2020English

A SARS-CoV-2/COVID-19 Em Pacientes Com Câncer

Revista Brasileira de Cancerologia
2020English

Call for Papers: The Pathophysiology of COVID-19 and SARS-CoV-2 Infection

American Journal of Physiology - Lung Cellular and Molecular Physiology
PulmonaryRespiratory MedicinePhysiologyCell Biology
2020English

COVID-19 Por SARS-CoV-2: La Nueva Emergencia De Salud

Revista Mexicana de Pediatria
Child HealthPediatricsPerinatology
2019English

Detection of Antibodies Against SARS-CoV-2 in Patients With COVID-19

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Update on the SARS-CoV-2 (COVID-19) Outbreak: A Global Pandemic Challenge

2020English

The Cholera Epidemics in Hamburg and What to Learn for COVID-19 (SARS-CoV-2)

Cytometry Part A
Forensic MedicinePathologyHistologyCell Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy